Copyright Reports & Markets. All rights reserved.

Global Transplantation Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Transplantation Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Kidney Transplantation
      • 1.4.3 Liver Transplantation
      • 1.4.4 Heart Transplantation
      • 1.4.5 Lung Transplantation
      • 1.4.6 Pancreas Transplantation
    • 1.5 Market by Application
      • 1.5.1 Global Transplantation Market Share by Application (2014-2025)
      • 1.5.2 Hospitals and Transplant Centers
      • 1.5.3 Diagnostic Registries and Research Laboratories
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Transplantation Market Size
    • 2.2 Transplantation Growth Trends by Regions
      • 2.2.1 Transplantation Market Size by Regions (2014-2025)
      • 2.2.2 Transplantation Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Transplantation Market Size by Manufacturers
      • 3.1.1 Global Transplantation Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Transplantation Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Transplantation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transplantation Key Players Head office and Area Served
    • 3.3 Key Players Transplantation Product/Solution/Service
    • 3.4 Date of Enter into Transplantation Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Transplantation Market Size by Type (2014-2019)
    • 4.2 Global Transplantation Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Transplantation Market Size (2014-2019)
    • 5.2 Transplantation Key Players in United States
    • 5.3 United States Transplantation Market Size by Type
    • 5.4 United States Transplantation Market Size by Application

    6 Europe

    • 6.1 Europe Transplantation Market Size (2014-2019)
    • 6.2 Transplantation Key Players in Europe
    • 6.3 Europe Transplantation Market Size by Type
    • 6.4 Europe Transplantation Market Size by Application

    7 China

    • 7.1 China Transplantation Market Size (2014-2019)
    • 7.2 Transplantation Key Players in China
    • 7.3 China Transplantation Market Size by Type
    • 7.4 China Transplantation Market Size by Application

    8 Japan

    • 8.1 Japan Transplantation Market Size (2014-2019)
    • 8.2 Transplantation Key Players in Japan
    • 8.3 Japan Transplantation Market Size by Type
    • 8.4 Japan Transplantation Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Transplantation Market Size (2014-2019)
    • 9.2 Transplantation Key Players in Southeast Asia
    • 9.3 Southeast Asia Transplantation Market Size by Type
    • 9.4 Southeast Asia Transplantation Market Size by Application

    10 India

    • 10.1 India Transplantation Market Size (2014-2019)
    • 10.2 Transplantation Key Players in India
    • 10.3 India Transplantation Market Size by Type
    • 10.4 India Transplantation Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Transplantation Market Size (2014-2019)
    • 11.2 Transplantation Key Players in Central & South America
    • 11.3 Central & South America Transplantation Market Size by Type
    • 11.4 Central & South America Transplantation Market Size by Application

    12 International Players Profiles

    • 12.1 AbbVie
      • 12.1.1 AbbVie Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Transplantation Introduction
      • 12.1.4 AbbVie Revenue in Transplantation Business (2014-2019)
      • 12.1.5 AbbVie Recent Development
    • 12.2 Arthrex
      • 12.2.1 Arthrex Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Transplantation Introduction
      • 12.2.4 Arthrex Revenue in Transplantation Business (2014-2019)
      • 12.2.5 Arthrex Recent Development
    • 12.3 Zimmer Biomet
      • 12.3.1 Zimmer Biomet Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Transplantation Introduction
      • 12.3.4 Zimmer Biomet Revenue in Transplantation Business (2014-2019)
      • 12.3.5 Zimmer Biomet Recent Development
    • 12.4 Medtronic
      • 12.4.1 Medtronic Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Transplantation Introduction
      • 12.4.4 Medtronic Revenue in Transplantation Business (2014-2019)
      • 12.4.5 Medtronic Recent Development
    • 12.5 Novartis
      • 12.5.1 Novartis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Transplantation Introduction
      • 12.5.4 Novartis Revenue in Transplantation Business (2014-2019)
      • 12.5.5 Novartis Recent Development
    • 12.6 Stryker
      • 12.6.1 Stryker Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Transplantation Introduction
      • 12.6.4 Stryker Revenue in Transplantation Business (2014-2019)
      • 12.6.5 Stryker Recent Development
    • 12.7 BioLifeSolutions
      • 12.7.1 BioLifeSolutions Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Transplantation Introduction
      • 12.7.4 BioLifeSolutions Revenue in Transplantation Business (2014-2019)
      • 12.7.5 BioLifeSolutions Recent Development
    • 12.8 Teva Pharmaceuticals
      • 12.8.1 Teva Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Transplantation Introduction
      • 12.8.4 Teva Pharmaceuticals Revenue in Transplantation Business (2014-2019)
      • 12.8.5 Teva Pharmaceuticals Recent Development
    • 12.9 Veloxis Pharmaceuticals
      • 12.9.1 Veloxis Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Transplantation Introduction
      • 12.9.4 Veloxis Pharmaceuticals Revenue in Transplantation Business (2014-2019)
      • 12.9.5 Veloxis Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
      M&A between small specialized hospitals and Tier-1 hospitals is one of the primary drivers for market growth. Rising acquisition of small hospitals by large tier-1 hospitals has led to the betterment of organ transplantation, wound care, and diagnosis that has indirectly impacted the growth of the transplantation market positively. These acquisitions assist in training the healthcare staff, including physicians and nurses, and patients are open to avail a range of patient monitoring equipment. Moreover, the brand name of the large hospitals attracts people to receive healthcare services that increase the requirement for transplant diagnostic products, assays, and kits. Also, M&A of small and medium-sized hospitals with large hospitals has increased the availability of services such as dedicated treatments for nephrology and cardiology, which in turn, meets the demands of patients.
      The Americas led the global transplantation market during 2017 and is foreseen to continue the domination during the forecast period. Factors like unhealthy dietary habits, consumption of alcohol, and severe diseases such as ESRD and liver cirrhosis leads to incidents of organ failure thus driving the demand for transplantation in the region.
      In 2018, the global Transplantation market size was 73000 million US$ and it is expected to reach 154200 million US$ by the end of 2025, with a CAGR of 9.8% during 2019-2025.

      This report focuses on the global Transplantation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transplantation development in United States, Europe and China.

      The key players covered in this study
      AbbVie
      Arthrex
      Zimmer Biomet
      Medtronic
      Novartis
      Stryker
      BioLifeSolutions
      Teva Pharmaceuticals
      Veloxis Pharmaceuticals

      Market segment by Type, the product can be split into
      Kidney Transplantation
      Liver Transplantation
      Heart Transplantation
      Lung Transplantation
      Pancreas Transplantation

      Market segment by Application, split into
      Hospitals and Transplant Centers
      Diagnostic Registries and Research Laboratories

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Transplantation status, future forecast, growth opportunity, key market and key players.
      To present the Transplantation development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Transplantation are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now